Caxton Associates (UK)’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
Caxton Associates (UK)'s CAH Position: Q2 2026 in Review
Caxton Associates (UK) reduced its Cardinal Health (CAH) stake by 64% in Q2 2026, selling an estimated $729K and leaving 1,998 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #546.
Caxton Associates (UK) first reported a position in CAH in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.26M in Q4 2025. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Caxton Associates (UK) held 1,998 shares of Cardinal Health worth $475K as of Q2 2026.
- Caxton Associates (UK) sold 3,509 Cardinal Health shares in Q2 2026, an estimated $729K.
- Cardinal Health made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #546 holding.
- Caxton Associates (UK) first reported a position in Cardinal Health in Q2 2025 and has held it in 4 quarters since.
- Caxton Associates (UK)'s Cardinal Health position peaked at $1.26M in Q4 2025.
- 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.